Table 3.

Anticoagulation delay and outcomes.

Outcomes at the final follow-up	Earlier anticoagulation (N=80)	Later anticoagulation (N=84)	p value
Primary outcome
mRS > 2, n (%)	12/80 (15.0)	11/84 (13.1)	0.788
Secondary outcomes
Residual headache, n (%)	15/76 (19.7)	28/79 (35.4)	0.029
Visual deficit, n (%)	12/76 (15.8)	19/79 (24.1)	0.199
Late seizure, n (%)	4/76 (5.3)	3/79 (3.8)	0.716
Neurologic deficit, n (%)	13/76 (17.1)	13/79 (16.5)	0.914

Abbreviations: mRS, modified Rankin Scale.